425671-29-0 Usage
Description
2-Methyl-2-[4-[3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl]phenoxy]propionic acid, also known as DPX-KN128, is a complex synthetic chemical compound that belongs to the class of propionic acid derivatives. It features a 1,2,4-triazole ring and a benzyl group, which contribute to its unique structure and properties. 2-Methyl-2-[4-[3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl]phenoxy]propionic acid is not naturally occurring and may have potential applications in pharmaceutical research and drug development.
Uses
Used in Pharmaceutical Research and Drug Development:
2-Methyl-2-[4-[3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl]phenoxy]propionic acid is used as a compound of interest in pharmaceutical research and drug development due to its unique structure and properties. Its potential applications may include the development of new drugs or therapies, as well as the enhancement of existing ones.
Further studies and research are needed to determine the specific uses and potential benefits of 2-Methyl-2-[4-[3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl]phenoxy]propionic acid in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 425671-29-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,2,5,6,7 and 1 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 425671-29:
(8*4)+(7*2)+(6*5)+(5*6)+(4*7)+(3*1)+(2*2)+(1*9)=150
150 % 10 = 0
So 425671-29-0 is a valid CAS Registry Number.
425671-29-0Relevant articles and documents
The role of new technologies in defining a manufacturing process for ppara agonist ly518674
Argentine, Mark D.,Braden, Timothy M.,Czarnik, Jeffrey,Conder, Edward W.,Dunlap, Steven E.,Fennell, Jared W.,LaPack, Mark A.,Rothhaar, Roger R.,Scherer, R. Brian,Schmid, Christopher R.,Vicenzi, Jeffrey T.,Wei, Jeffrey G.,Werner, John A.,Roginski, Robert T.
experimental part, p. 131 - 143 (2010/04/22)
The impact of several new technologies on the development of a manufacturing process for LY518674 is described. Extensive use of process analytical technology (PAT) throughout development, both at laboratory and pilot-plant scale, enabled data-rich experi
The synthesis of three isotopomers of 2-methyl-2-(4-[3-[1-(4-methylbenzyl)- 5-oxo-4,5-dihydro-1H-[1,2,4]triazol-3-yl]propyl]phenoxy)propionic acid, a potent and selective peroxisome proliferator-activated receptor alpha agonist
Kou, Fengjiun,Clodfelter, Dean K.,Farid, Nagy A.,Wheeler, William J.,Mckendry, Lennon H.
, p. 693 - 701 (2008/02/10)
Although fenofibrate (1a) is commercially available and clinically effective in lowering serum triglycerides, its activity and sub-type selectivity at the PPARα receptors are only moderate; therefore, there exists a need for more potent and sub-type selec